 | | | | - Compared with industrial index, the Return comparison Volatility was negative | | - Related stocks mixed, Medical Supplies industry -1.23% | | - Target price KRW 15,000, has 74% disparate to increase compared with stock price. | | - Institutions and Foreigners sell, Individuals buy | | - Turnover Rate and Price Range both proper | | - Participation of Foreigners is active, 18.68% |
|
|
As of Oct. 24 02:10 P.M., Kwangdong Pharmaceutical slightly edged down 0.92% to 8,610 (US$ 7.59). It had declined 6% through the past month. Standard deviation, the risk index for stock price, was 1.6% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, even though the monthly earnings rate of Kwangdong Pharmaceutical stayed negative, its volatility for 1 month was at the lowest level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -3.7%. As the volatility was low, the return-on-risk was a proper rate in spite of stock price decline. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, -0.5, and thus it is hard to say that the industrial comparison performance was positive.
Comparing industry to the market, the KOSPI industry including Kwangdong Pharmaceutical records higher volatility but lower earning rate than Medical Supplies. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.
| Close Competitors | Earning rate (%) | STD (1Mo) | Return on
Risk (1Mo) | | 1 Mo | 3 Mo | 6 Mo | | HANALL BIOPHARMA(009420) | -29.5% | -39.5% | -11.8% | 3.2% | -9.2 | | IL DONG PHARM(249420) | -2.9% | % | % | 2.8% | -1.0 | | SAMJIN PHARM(005500) | -3.5% | -6.7% | 16.1% | 2.2% | -1.6 | | BORYUNG PHARM(003850) | -7.6% | -6.7% | 6.6% | 1.8% | -4.2 | | KWANGDONG PHARM(009290) | -6.0% | -11.5% | -21.4% | 1.6% | -3.7 | | | | Medical Supplies | -17.0% | -16.8% | -21.7% | 1.7% | -10.0 | | KOSPI | -0.3% | -0.7% | 1.2% | 0.6% | -0.5 |
|
Target price KRW 15,000, has 74% disparate to increase compared with stock price.
Per analysts' expectations during the recent month, the average target price of KWANGDONG PHARM is KRW 15,000. The stock price is KRW 8,610 as of yesterday, so there is KRW 6,390 (74%) disparate in order to be able to increase.
KWANGDONG PHARM(009290): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)
| | Revenue | Operating Income | Net Income | | 2Q of 2016 | 2,783.4 T | 133.2 T | 94.2 T | | Previous Quarter | 13.9% increase | 19.9% increase | 14.1% increase | | YoY | 0.3% decline | 12.8% decline | 17.4% decline |
|
Institutions and Foreigners sell, Individuals buy
From Oct. 12, foreigners have been continuously selling Kwangdong Pharmaceutical during the past 8 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have sold 311,130 shares with maintenance of a selling position and institutions have sold 34,072 shares with a selling trend. However, during the same period, individuals have bought 345,202 shares with an increasing position.
Turnover Rate and Price Range both proper
Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of Kwangdong Pharmaceutical was 0.25%. And the daily volatility, the average range of rise and fall, during the same period is 1.26%.
Participation of Foreigners is active, 18.68%
As per the inquiry for shareholding by investor group, the major investor group is individuals with 73.14% from total outstanding shares. Foreigners and institutions each hold 18.68% and 8.16%. And as recent 5-day shareholding change by investor group, individuals is the major investor group with 73.23%. Foreigners hold 20.61% and institutions hold 6.14%.
| Cumulated shareholdings per investor group (1Mo) | | Total shareholdings per investor group |  | |  |
| * Other Investor groups, included as "other corporations", are considered as "Individuals". |
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp. |
![[KH Explains] No more 'Michael' at Kakao Games](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/04/28/20240428050183_0.jpg&u=20240428180321)
